Lobbying disclosures · Lobbying report
COR: second_quarter 2026 lobbying report
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortage Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicares Part B Physician Fee Schedule CMS ASP Certification Medicare physician reimbursement CY2026 Medicare Physi
Follow COR- Became public
- Jul 20, 2026, 3:59 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 1:12 PM EST
Why this is connected
Exact legal-name match: Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/).
Reported lobbying amounts
Expenses: $510,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/93be79b4-aac0-4292-abde-895184a3f527/","filing_uuid":"93be79b4-aac0-4292-abde-895184a3f527","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/93be79b4-aac0-4292-abde-895184a3f527/print/","filing_document_content_type":"text/html","income":null,"expenses":"510000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Vivienne E. S. Mitchell","dt_posted":"2026-07-20T15:59:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"412 1st Street SE, Suite 200","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":293756,"url":"https://lda.gov/api/v1/registrants/293756/","house_registrant_id":37387,"name":"CENCORA, INC.","description":"Pharmaceutical Distributor","address_1":"412 1st Street SE, Suite 200","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"VIVIENNE E. S. MITCHELL","contact_telephone":"2021343501","dt_updated":"2026-07-21T09:30:16.492929-04:00"},"client":{"id":178667,"url":"https://lda.gov/api/v1/clients/178667/","client_id":12,"name":"CENCORA, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2005-01-05"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortage Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicares Part B Physician Fee Schedule CMS ASP Certification Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule Distributor bona fide service fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Preventing and mitigating generic drug shortages Ensuring Seniors Access to Critical Medications Act/ Main Street Pharmacy Access Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act (NDAA - H.R.8800) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS FY 2026 Medicares Part B Physician Fee Schedule Rule CMS ASP Certification Break Up Big Medicine Act (S. 3822) Management Services Organization (MSO) Role and value of community specialty physicians and MSOs Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Global Intangible Low-taxed Income (GILTI) Territorial Economic Recovery Act (H.R. 363) The Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act (H.R. 3042) Restore Economic Vitality and Investment in the Virgin Islands Act (REVIVE VI Act) (858)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66284,"prefix":null,"prefix_display":null,"first_name":"VIVIENNE","nickname":null,"middle_name":"STAFFORD","last_name":"MITCHELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145130,"prefix":null,"prefix_display":null,"first_name":"DARRELL","nickname":null,"middle_name":null,"last_name":"ROGERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142272,"prefix":null,"prefix_display":null,"first_name":"SHELLY","nickname":null,"middle_name":null,"last_name":"MUI-LIPNIK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153774,"prefix":null,"prefix_display":null,"first_name":"FREDERICK","nickname":null,"middle_name":null,"last_name":"ESSIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154231,"prefix":"mr","prefix_display":"MR.","first_name":"COREY","nickname":null,"middle_name":"AUSTIN","last_name":"MCGEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in COR
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
Traded 14 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026
Got $1K from the company’s PAC - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026 · Dependent
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 31, 2026 · disclosed Apr 30, 2026
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026 · Dependent
Got $1K from the company’s PAC
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.